Bihua Chen Transaction History

Date Transaction Value Shares Traded Form
Aug 11 2025
SELL
Sale (or disposition) back to the issuer
-
152,940
Aug 11 2025
BUY
Exercise of conversion of derivative security
-
4,172,126
Aug 11 2025
BUY
Grant, award, or other acquisition
$117,388,373 $10.72 p/Share
10,950,408
Feb 13 2024
BUY
Grant, award, or other acquisition
$5,090,000 $10.0 p/Share
509,000
Feb 13 2024
BUY
Open market or private purchase
$24,000,000 $10.0 p/Share
2,400,000

Also insider at

MLTX
MoonLake Immunotherapeutics Healthcare
BMEA
Biomea Fusion, Inc. Healthcare
ERAS
Erasca, Inc. Healthcare
BC

Bihua Chen

Director
Boston, MA

Track Institutional and Insider Activities on HLXB

Follow Helix Acquisition Corp. II and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HLXB shares.

Notify only if

Insider Trading

Get notified when an Helix Acquisition Corp. Ii insider buys or sells HLXB shares.

Notify only if

News

Receive news related to Helix Acquisition Corp. II

Track Activities on HLXB